COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center.
BMC Infect Dis
; 23(1): 105, 2023 Feb 22.
Article
em En
| MEDLINE
| ID: mdl-36814187
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
COVID-19
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article